1. Home
  2. MEC vs TSHA Comparison

MEC vs TSHA Comparison

Compare MEC & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

HOLD

Current Price

$25.29

Market Cap

482.6M

Sector

Industrials

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.46

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEC
TSHA
Founded
1945
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.6M
1.8B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
MEC
TSHA
Price
$25.29
$5.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$24.33
$11.63
AVG Volume (30 Days)
346.4K
2.1M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.56
EPS
N/A
N/A
Revenue
N/A
$9,773,000.00
Revenue This Year
$10.65
N/A
Revenue Next Year
$8.66
$1,152.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.28
52 Week Low
$12.10
$2.25
52 Week High
$28.00
$7.30

Technical Indicators

Market Signals
Indicator
MEC
TSHA
Relative Strength Index (RSI) 59.69 41.58
Support Level $17.20 $5.37
Resistance Level $28.00 $6.02
Average True Range (ATR) 1.89 0.43
MACD -0.26 -0.20
Stochastic Oscillator 61.21 14.32

Price Performance

Historical Comparison
MEC
TSHA

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: